https://www.lwbpsh.com/website/info https://www.lwbpsh.com/blog https://www.lwbpsh.com/jobs https://www.lwbpsh.com/ https://www.lwbpsh.com/jobs https://www.lwbpsh.com/jobs https://www.lwbpsh.com/jobs https://www.lwbpsh.com/jobs https://www.lwbpsh.com/jobs https://www.lwbpsh.com/jobs https://www.lwbpsh.com/jobs https://www.lwbpsh.com/jobs https://www.lwbpsh.com/jobs https://www.lwbpsh.com/jobs https://www.lwbpsh.com/jobs https://www.lwbpsh.com/jobs https://www.lwbpsh.com/jobs https://www.lwbpsh.com/jobs https://www.lwbpsh.com/jobs https://www.lwbpsh.com/jobs/detail/analytical-researcher-74 https://www.lwbpsh.com/jobs/detail/clinical-program-operation-manager-69 https://www.lwbpsh.com/jobs/detail/director-of-clinical-operations-china-70 https://www.lwbpsh.com/jobs/detail/organic-synthesis-team-member-73 https://www.lwbpsh.com/jobs/detail/regulatory-registration-senior-manager-68 https://www.lwbpsh.com/jobs/detail/senior-organic-synthesis-researcher-72 https://www.lwbpsh.com/jobs/detail/senior-researcher-in-pharmacology-and-toxicology-71 https://www.lwbpsh.com/jobs/apply/analytical-researcher-74 https://www.lwbpsh.com/jobs/apply/clinical-program-operation-manager-69 https://www.lwbpsh.com/jobs/apply/director-of-clinical-operations-china-70 https://www.lwbpsh.com/jobs/apply/organic-synthesis-team-member-73 https://www.lwbpsh.com/jobs/apply/regulatory-registration-senior-manager-68 https://www.lwbpsh.com/jobs/apply/senior-organic-synthesis-researcher-72 https://www.lwbpsh.com/jobs/apply/senior-researcher-in-pharmacology-and-toxicology-71 https://www.lwbpsh.com/blog/news-3/feed https://www.lwbpsh.com/blog/news-3/lwbp-newsnext-generation-highly-selective-jak1-inhibitor-lw402-enrolls-first-patient-in-phase-3-clinical-trial-for-atopic-dermatitis-ad-39 https://www.lwbpsh.com/blog/news-3/lwbp-newsworld-s-first-bi-functional-dual-target-drug-for-complete-cure-of-hepatitis-b-lw231-successfully-enrolls-the-first-subject-of-phase-ib-ii-clinical-trial-38 https://www.lwbpsh.com/blog/news-3/lwbp-newsdr-zhe-wang-invited-to-attend-the-pre-conference-meeting-of-bio-forum2025-and-deliver-a-keynote-speech-37 https://www.lwbpsh.com/blog/news-3/lwbp-newslongwood-biopharmaceuticals-secures-hundreds-of-millions-of-rmb-in-series-b-financing-to-accelerate-core-pipeline-clinical-research-and-global-layout-36 https://www.lwbpsh.com/blog/news-3/lwbp-news-world-s-first-bi-functional-dual-target-drug-for-complete-cure-of-hepatitis-b-lw231-officially-initiates-phase-ib-ii-clinical-trial-35 https://www.lwbpsh.com/blog/news-3/lwbp-newslwbp-s-independently-developed-bi-function-hepatitis-b-new-drug-lw231-participated-at-the-11th-china-shanghai-international-technology-fair-34 https://www.lwbpsh.com/blog/news-3/lwbp-newsnext-generation-oral-jak1-selective-inhibitor-lw402-clinical-phase-ii-study-in-atopic-dermatitis-completes-enrollment-of-all-subjects-33 https://www.lwbpsh.com/blog/news-3/lwbp-newslw402-a-new-generation-oral-jak1-selective-inhibitor-demonstrated-amazing-results-in-clinical-phase-ii-study-for-rheumatoid-arthritis-32 https://www.lwbpsh.com/blog/news-3/lwbp-newslw402-a-next-generation-oral-jak1-selective-inhibitor-independently-developed-by-lwbp-was-approved-for-clinical-studies-in-vitiligo-30 https://www.lwbpsh.com/blog/news-3/lwbp-newslwbp-releases-updated-data-on-lw231-a-self-developed-novel-hepatitis-b-drug-at-aasld2023-the-liver-meeting-28 https://www.lwbpsh.com/blog/news-3/lwbp-newslwbp-was-awarded-grand-neo-bay-2023-top-10-innovative-and-entrepreneurial-enterprise-biomedical-sector-27 https://www.lwbpsh.com/blog/news-3/lwbp-newslwbp-wins-the-first-prize-of-the-fifth-lianyungang-huaguo-mountain-talents-innovation-and-entrepreneurship-competition-2023-26 https://www.lwbpsh.com/blog/news-3/lwbp-newssecond-generation-jak1-selective-inhibitor-lw402-clinical-phase-ii-trial-demonstrates-positive-progress-25 https://www.lwbpsh.com/blog/news-3/phase-ii-clinical-study-of-a-new-generation-oral-small-molecule-jak1-selective-inhibitor-for-multiple-indications-successfully-initiated-23 https://www.lwbpsh.com/blog/news-3/new-class-i-bifunctional-hepatitis-b-drug-makes-clinical-positive-progression-22 https://www.lwbpsh.com/blog/news-3/longwood-biopharmaceuticals-initiates-clinical-phase-ii-study-of-lw402-a-next-generation-jak1-inhibitor-21 https://www.lwbpsh.com/blog/news-3/longwoodpharmaceuticals-deeply-committed-to-the-pharmaceutical-industry-contributing-to-the-health-of-china-10 https://www.lwbpsh.com/blog/news-3 https://www.lwbpsh.com/contact 2023-03-30 https://www.lwbpsh.com/about-us 2023-03-26 https://www.lwbpsh.com/careers 2022-12-21 https://www.lwbpsh.com/copyrights 2023-03-08 https://www.lwbpsh.com/open-jobs 2022-12-22 https://www.lwbpsh.com/research 2023-12-18 https://www.lwbpsh.com/our-services 2022-12-08